Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00IWL
|
|||
Former ID |
DIB009029
|
|||
Drug Name |
PolyHeme
|
|||
Synonyms |
Oxygen-carrying blood substitute, Northfield Laboratories
Click to Show/Hide
|
|||
Indication | Blood forming organ disorder [ICD-11: JB64.1; ICD-10: O99.1] | Phase 3 | [1] | |
Company |
Northfield Laboratories
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C13H18NO8P
|
|||
Canonical SMILES |
CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O.C(CC=O)CC=O
|
|||
InChI |
1S/C8H10NO6P.C5H8O2/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-4-2-1-3-5-7/h2-3,11H,4H2,1H3,(H2,12,13,14);4-5H,1-3H2
|
|||
InChIKey |
SKKYPUWZZNPUMG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00076648) Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting. U.S. National Institutes of Health. | |||
REF 2 | Blood substitutes- the polyheme trials. Mcgill J Med. 2008 January; 11(1): 59-65. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.